Literature DB >> 9215194

Evaluation of sexual misconduct complaints: the Oregon Board of Medical Examiners, 1991 to 1995.

J A Enbom1, C D Thomas.   

Abstract

OBJECTIVE: In 1991 the Oregon Board of Medical Examiners initiated a separate category for the complaint of sexual misconduct. Investigated complaints of sexual misconduct brought to the Oregon Board of Medical Examiners were analyzed for the years 1991 to 1995 to serve as a baseline. Comparison was made to the Federation of State Medical Boards sexual misconduct data for 1991 and 1992. STUDY
DESIGN: One hundred complaints brought against 80 licensees were evaluated by practitioner's degree, age group, sex, specialty, and disposition of complaints for the years 1991 to 1995. The allegations were classified into behavior categories of sexual impropriety, sexual transgression, and sexual violations.
RESULTS: Sexual misconduct was the allegation in 5.9% of the complaints investigated for the study period. Oregon had more sexual misconduct complaints than the average reported to the Federation of State Medical Boards for the years 1991 and 1992. Most (72%) complaints came from the patients or their families. Two female physicians (2.4%) had sexual boundary complaints. Sexual misconduct complaints increased by a risk ratio of 1.44 with advancing age by decades. Allegations classified into behavior categories according to severity revealed 39% sexual impropriety, 31% sexual transgression, and 30% sexual violation. Reportable disciplinary actions occurred only with multiple allegations of sexual impropriety (6.5%) and for sexual transgression (27%) whereas sexual violation allegations often had one complainant but there were 54% reportable disciplinary actions. Family practice, obstetrics and gynecology, and psychiatry had the highest incidence of sexual misconduct complaints whereas psychiatry and obstetrics and gynecology had the highest incidence of reportable disciplinary actions. Twenty-five percent of the closed cases resulted in reportable disciplinary actions. This analysis is discussed in relationship to legal and ethical issues and the goal of zero tolerance.
CONCLUSIONS: Oregon has a higher percentage of sexual misconduct complaints than the average for 42 states reporting to the Federation of State Medical Boards for the years 1991 and 1992. Analysis of the Oregon Board's experience for the study years will provide a baseline for future evaluation and as an educational resource for the Oregon Board of Medical Examiners and professional and specialty societies. Ethical standards, the reporting and investigative processes, and the legal framework are in place and lessen the incidence of sexual misconduct and work toward zero tolerance.

Entities:  

Keywords:  Empirical Approach; Oregon Board of Medical Examiners; Professional Patient Relationship

Mesh:

Year:  1997        PMID: 9215194     DOI: 10.1016/s0002-9378(97)70355-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Crossing the line: sexual boundary violations by physicians.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-06

2.  Sex and the surgery: students' attitudes and potential behaviour as they pass through a modern medical curriculum.

Authors:  J Goldie; L Schwartz; J Morrison
Journal:  J Med Ethics       Date:  2004-10       Impact factor: 2.903

3.  Something in nothing: negative space in the clinician-patient relationship.

Authors:  Stephen A Buetow
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

4.  Cross-Sectional Analysis of the 1039 U.S. Physicians Reported to the National Practitioner Data Bank for Sexual Misconduct, 2003-2013.

Authors:  Azza AbuDagga; Sidney M Wolfe; Michael Carome; Robert E Oshel
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

5.  The characteristics of psychiatrists disciplined by professional colleges in Canada.

Authors:  Asim Alam; Paul Kurdyak; Jason Klemensberg; Joshua Griesman; Chaim M Bell
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.